Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2000

View Archived Issues

Immune Response synthesizes new factor VIII gene

Cantab makes steady progress during 1999

Reticulose cleared for clinical trials in Argentina

FDA advisory committee meeting canceled

OSI Pharmaceuticals makes forward strides during Q1 2000

NCI begins phase II trial of O6-benzylguanine/carmustine as glioma therapy

Biomira updates product pipeline

Gilead reviews progress in 1999

Oxigene to develop CA4P for eye, skin and joint disorders

Life-saving treatment for pulmonary hypertension in newborn babies featured in NEJM

New phenethylsulfones synthesized at Celgene useful for inflammation, etc.

Lilly's new 5-ht1f receptor antagonists covered by two European patents

Cell Pathways presents apoptosis-promoting compounds

Gene therapy improves age-related cardiac disorder in rats

New compounds with ampakine-like activity in development at Lilly

Novirio claims large group of HIV RT inhibitors

Cantharidin analogues as protein phosphatase inhibitors: use in cancer therapy

Antiparasitic artemisinin derivatives designed at Hong Kong university

New antiepileptic Diastat available in Canada for ARS

Early clinical trial in Japan demonstrates safety, favorable pharmacokinetics of CGS-19755

CPMP issues positive opinion regarding PEG-Intron MAA

Antifungal activity of brasilinolide B described by Japanese research team

Switch Biotech files patent applications for wound-healing genes

Approvable letter issued by FDA for Texas Biotechnology's Novastan

Paladin licenses Uniprost to United Therapeutics in Canada

Trichobitacin: anti-HIV RIP purified from Chinese medicinal herb

Monsanto and P&U to hold special shareholder meetings to vote on proposed merger

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...